The Cancer Research Institute (CRI) is a not-for-profit founded in 1953 with a singular mission of saving more lives by fueling the discovery and development of powerful immunotherapies for all cancers. CRI is a pioneer and leader in bringing immunotherapies to more cancer patients by:

1. seeking innovative partnerships with biotech and pharmaceutical companies that are developing promising immunotherapies in their drug pipelines;

2. collaborating with disease-specific cancer charities seeking to extend their research portfolio into clinical immunology;

3. funding basic science and training future generations of scientists; and

4. educating patients and caregivers about their immunotherapy treatment options and encouraging them to advance research through participation in clinical trials.